Avandia Faces Lawsuit from a California County

Santa Clara County in California has filed a civil lawsuit against the manufacturer of diabetes drug Avandia. GlaxoSmithKline is the defendant in the lawsuit which seeks damages from all Santa Clara County Avandia users who were mislead by GlaxoSmithKline. The suit alleges GSK failed to warn potential consumers of the associated risks of heart attacks that studies have shown are attributable to Avandia.
Avandia has been dogged by controversy and studies linking it to an increased risk of heart attacks in those Type 2 diabetes patients who are prescribed the drug. During the third quarter of 2009, Avandia was linked to 304 deaths. Two FDA doctors, Dr. David Graham and Dr. Kate Gelperin, have called for an Avandia recall after the doctors reviewed scientific research linking the drug to higher heart attack risk. GlaxoSmithKline officials have fought recall efforts and continue to insist the cardiac risk link is bogus. The problem with Avandia began in 2007 after a Cleveland Clinic cardiologist link Avandia with heart attacks. Since that time, Avandia’s manufacturer has tried to prop its $3.2 billion diabetes drug.
According to county offiicals, the lawsuit seeks treble damages since GlaxoSmithKline’s marketing campaign targeted diabetics who are recognized as disabled by the State of California.